Therapeutics for Women's Health: Technologies and Global Markets

  • ID: 3743712
  • Report
  • Region: Global
  • 230 Pages
  • BCC Research
15 % OFF
until Dec 31st 2018
1 of 5

FEATURED COMPANIES

  • Abbvie
  • Bayer
  • Eli Lilly
  • Mochida Pharma Co. Ltd.
  • Otsuka Holdings
  • Repros Therapeutics Inc.
  • MORE
The global market for women’s health therapeutics will grow from nearly $33.0 billion in 2015 to nearly $40.6 billion by 2020, with a compound annual growth rate (CAGR) of 4.2% for the period of 2015-2020.

This report provides:

- An overview of the global market for women's health therapeutics.
- Analyses of global market trends, with data from 2014, 2015, and projections of CAGRs through 2020.
- Information on women's health disorder types including infertility, endometriosis, postmenopausal osteoporosis, menopause, and polycystic ovary syndrome (PCOS).
- Detailed analysis of annual costs as well discussion on branded vs. generic options.
- Specifics on market factors such as drivers, restraints, and competition.
- Information on marketed as well as pipeline drugs and therapies.
- Profiles of major players in the industry.

Scope of the report:

This report is an analytical business tool whose primary purpose is to describe the thorough evaluation of the global market for women’s health therapeutics. The format of the study is organized around the following topics:

- Detailed study around women’s diseases such as endometriosis, postmenopausal osteoporosis, menopause, breast cancer and polycystic ovary syndrome (PCOS).
- Disease incidence and prevalence.
- Regulatory structure.
- Market characterization, unmet need, market size and segmentation.
- Market drivers and restraints.
- Detailed market projections through 2020.
- Competition and market shares.
- Pricing and reimbursement.
- Marketed and pipeline (R&D) products along with description, regulatory status and clinical trials.
- Observations and conclusions regarding the future of women’s health therapeutics market.
- Profiles of market participants and associations.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbvie
  • Bayer
  • Eli Lilly
  • Mochida Pharma Co. Ltd.
  • Otsuka Holdings
  • Repros Therapeutics Inc.
  • MORE
Chapter 1: Introduction
- Study Background
- Study Goals And Objectives
- Intended Audience
- Scope Of The Report
- Methodology And Information Sources
- Analyst's Credentials

Chapter 2: Summary

- Executive Summary

Chapter 3: Overview Of Women's Health Disorders

- Disease Overview And Definitions
- Historical Background
- Aging And Women's Health Disorders
- New Use For Contraceptives
- Women And Sexual Health
- Infertility And Cancer

Chapter 4: Menopause-Related Symptoms And Diseases

- Overview
- Etiology
- Epidemiology And Economic Burden
- Symptoms Of Menopause
- Risk Factors For Early Onset Menopause
- Diagnosis And Treatment

Chapter 5: Postmenopausal Osteoporosis

- Disease Overview
- Epidemiology And Economic Burden
- Disease Symptoms And Risk Factors
- Diagnosis And Treatment

Chapter 6: Endometriosis

- Disease Overview
- Etiology And Pathophysiology
- Disease Symptoms And Risk Factors
- Stages Of Endometriosis
- Epidemiology And Economic Burden
- Diagnosis And Treatment

Chapter 7: Polycystic Ovary Syndrome

Chapter 8: Breast Cancer

- Disease Overview
- Etiology And Pathophysiology
- Disease Symptoms And Risk Factors
- Types And Stages Of Breast Cancer
- Epidemiology And Economic Burden
- Diagnosis And Treatment

Chapter 9: Women's Health Disorder Therapeutics Market Assessment

- Global Women's Health Market
- Annual Cost Of Therapy

Chapter 10: Competition And Market Shares
- Table 15 : Leading Companies In The Global Market For Women's Health Therapeutics, 2015
- Figure 29 : Global Market Shares Of Leading Companies In Women's Health Therapeutics Industry, 2015

Chapter 11: Market Strategy

- Mergers And Acquisitions
- Table 16 : Key Mergers/Acquisitions Within The Women’S Health Market, 2009-January 2016

Chapter 12: Drug Pipeline Analysis

- Drugs Under Development
- Table 17 : Pipeline Drugs In Women's Health

Chapter 13: Regulatory Structure

- United States
- Europe
- Japan

Chapter 14: Pricing And Reimbursement

- United States
- Europe
- Japan

Chapter 15: Conclusions-Outlook For Women's Health Therapeutics

- Major Developments To Influence Market
- Future Outlook

Chapter 16: Company Profiles

- Abbvie
- Allergan
- Amgen
- Asahi Kasai
- Astellas Pharma Inc.
- Astrazaneca
- Bayer
- Bionovo
- Celgene
- Chugai Pharmaceuticals
- Depomed Inc.
- Eisai
- Eli Lilly
- Endoceutics
- Forendo Pharma Oy
- Glaxosmithkline
- Ipsen SA
- Les Laboratories Servier Sas
- Merck
- Mochida Pharma Co. Ltd.
- Meditrina Pharmaceuticals Inc.
- Neurocrine Biosciences Inc.
- Novartis AG
- Novo Nordisk A/S
- Novogyne Pharmaceuticals
- Oasmia Pharmaceutical
- Orion Pharma Ltd.
- Otsuka Holdings
- Paladin Labs Inc.
- Pfizer Inc.
- Preglem SA
- Puma Biotechnology
- Roche
- Radius Health Inc.
- Repros Therapeutics Inc.
- Sanofi
- Takeda Pharmaceutical
- Tarsa Therapeutics Inc.
- Teva Pharmaceutical Industries
- Therapeuticsmd
- Tsumura & Co.
- Warner Chilcott Corp. (Subsidiary Of Actavis)
- Ziopharm Oncology
- Zosano Pharma Inc.

Chapter 17: Industry And Professional Organizations

- American Association For Cancer Research (Aacr)
- American Cancer Society
- American Society For Reproductive Medicine (Asrm)
- American Society Of Breast Surgeons
- American Society Of Clinical Oncology (Asco)
- Androgen Excess And Pcos Society
- Asia-Pacific Menopause Federation
- Avon Breast Cancer Crusade
- Breastcancer.Org
- Endometriosis Association
- Endometriosis Foundation Of America (Efa)
- Endometriosis.Org
- Endometriosis Research Centre (Erc)
- Endometriosis U.K.
- European Cancer Observatory
- European Endometriosis League (Eel)
- European Menopause And Andropause Society (Emas)
- European Society Of Human Reproduction And Embryology (Eshre)
- Food And Drug Administration (Fda)
- Global Cancer Foundation
- Hormone Foundation
- International Agency For Research On Cancer
- International Federation Of Pharmaceutical Manufacturers & Associations (Ifpma)
- International Menopause Society (Ims)
- International Osteoporosis Foundation (Iof)
- Japan Endometriosis Association (Jema)
- Japan Society For Menopause And Women's Health
- Japanese Breast Cancer Society
- National Center For Biotechnology Information (Ncbi)
- National Comprehensive Cancer Network (Nccn)
- National Institute On Aging (Nia)
- North American Menopause Society (Nams)
- National Osteoporosis Foundation (Nof)
- National Women's Health Information Center (Nwhic)
- Pcosupport
- World Cancer Research Fund International
- World Endometriosis Research Foundation (Werf)
- Worldwide Cancer Research

Chapter 18: Abbreviations

List Of Tables

Summary Table : Global Market For Women's Health Therapeutics, Through 2020
Table 1 : Global General Female Population Vs Population Suffering From A Women's Disorder, Through 2020
Table 2 : Global Prevalence Of Menopause-Related Conditions By Region, Through 2020
Table 3 : Commonly Prescribed Drugs Used To Treat The Symptoms Of Menopause
Table 4 : Global Prevalence Of Postmenopausal Osteoporosis By Region, Through 2020
Table 5 : Commonly Prescribed Drugs Used To Treat Postmenopausal Osteoporosis
Table 6 : Prevalence Of Endometriosis By Region, Through 2020
Table 7 : Drugs Commonly Used To Treat Endometriosis
Table 8 : Prevalence Of Polycystic Ovary Syndrome By Region, Through 2020
Table 9 : Commonly Prescribed Generic Drugs For The Treatment Of Polycystic Ovary Syndrome
Table 10 : Tnm Classifications Of Breast Cancers
Table 11 : Five-Year Survival Rate Based On Stage Of Breast Cancer For Women In The U.S, 2015
Table 12 : Prevalence Of Breast Cancer By Region, Through 2020
Table 13 : Types Of Hormone Therapy For Breast Cancer
Table 14 : Drugs Commonly Used To Treat Breast Cancer
Table 15 : Leading Companies In The Global Market For Women's Health Therapeutics, 2015
Table 16 : Key Mergers/Acquisitions Within The Women’S Health Market, 2009-January 2016
Table 17 : Pipeline Drugs In Women's Health
Table 18 : Estimates Of Anticipated U.S. Life Expectancy At Birth And Projections By Gender, 2005-2020
Table 19 : Projected Global Female Population By Age, Through 2030
Table 20 : Projected U.S. Female Population By Age, 2000-2030
Table 21 : Projected European Female Population By Age, 2000-2030
Table 22 : Projected Japan Female Population By Age, 2000-2030
Table 23 : Projected Trends In Per Capita Real Gdp Growth By Region, 2015-2020

List Of Figures

Summary Figure : Global Market For Women's Health Therapeutics, 2014-2020
Figure 1 : Distribution Of Global Population Suffering From A Women's Disorder By Type, 2015
Figure 2 : Female Likelihood Of Becoming Pregnant Versus Infertility As Age Progresses, 2015
Figure 3 : Global Prevalence Of Menopause-Related Conditions By Region, 2014-2020
Figure 4 : Global Population Of Females Suffering From Menopause-Related Conditions Vs The General Female Population, 2014-2020
Figure 5 : Global Distribution Of Females Suffering From Menopause-Related Conditions By Region, 2015
Figure 6 : Global Prevalence Of Postmenopausal Osteoporosis By Region, 2014-2020
Figure 7 : Global Population Of Females With Postmenopausal Osteoporosis Vs The Overall Female Population, 2014-2020
Figure 8 : Global Distribution Of Females With Postmenopausal Osteoporosis By Geographic Region, 2015
Figure 9 : Prevalence Of Endometriosis By Region, 2014-2020
Figure 10 : Global Endometriosis Population Vs Overall Female Population, 2014-2020
Figure 11 : Global Distribution Of Endometriosis Population By Region, 2015
Figure 12 : Prevalence Of Polycystic Ovary Syndrome By Region, 2014-2020
Figure 13 : Global Polycystic Ovary Syndrome Disease Population Vs Female Population, 2014-2020
Figure 14 : Global Distribution Of Polycystic Ovary Syndrome Population By Region, 2015
Figure 15 : Prevalence Of Breast Cancer By Region, 2014-2020
Figure 16 : Global Breast Cancer Population Vs Overall Female Population, 2014-2020
Figure 17 : Global Distribution Of Breast Cancer Population By Region, 2015
Figure 18 : Global Women's Health Therapeutics Market By Region, 2014-2020
Figure 19 : Global Women's Health Therapeutics Market By Disorder Type, 2014-2020
Figure 20 : Global Market Shares Of Women's Health Therapeutics Market By Disorder Type, 2015
Figure 21 : Average Annual Cost Of Therapy For Women's Health Disorders, 2014-2020
Figure 22 : Global Endometriosis Therapeutics Market By Region, 2014-2020
Figure 23 : Global Market For Therapeutics To Treat Menopause-Related Conditions By Region, 2014-2020
Figure 24 : Global Postmenopausal Osteoporosis Therapeutics Market By Region, 2014-2020
Figure 25 : Global Market For Polycystic Ovary Syndrome Therapeutics By Region, 2014-2020
Figure 26 : Global Breast Cancer Therapeutics Market By Region, 2014-2020
Figure 27 : Global Average Annual Cost Of Therapy By Disorder, 2014-2020
Figure 28 : Global Shares Of Women's Health Therapeutics Market: Branded Vs. Generic, 2015
Figure 29 : Global Market Shares Of Leading Companies In Women's Health Therapeutics Industry, 2015
Figure 30 : Estimates Of Anticipated U.S. Life Expectancy At Birth And Projections By Gender, 2005-2020
Figure 31 : Projected Global Female Population By Age, 2000-2030
Figure 32 : Projected U.S. Female Population By Age, 2000-2030
Figure 33 : Projected European Female Population By Age, 2000-2030
Figure 34 : Projected Japan Female Population By Age, 2000-2030
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
- Abbvie
- Allergan
- Amgen
- Asahi Kasai
- Astellas Pharma Inc.
- Astrazaneca
- Bayer
- Bionovo
- Celgene
- Chugai Pharmaceuticals
- Depomed Inc.
- Eisai
- Eli Lilly
- Endoceutics
- Forendo Pharma Oy
- Glaxosmithkline
- Ipsen SA
- Les Laboratories Servier Sas
- Merck
- Mochida Pharma Co. Ltd.
- Meditrina Pharmaceuticals Inc.
- Neurocrine Biosciences Inc.
- Novartis AG
- Novo Nordisk A/S
- Novogyne Pharmaceuticals
- Oasmia Pharmaceutical
- Orion Pharma Ltd.
- Otsuka Holdings
- Paladin Labs Inc.
- Pfizer Inc.
- Preglem SA
- Puma Biotechnology
- Roche
- Radius Health Inc.
- Repros Therapeutics Inc.
- Sanofi
- Takeda Pharmaceutical
- Tarsa Therapeutics Inc.
- Teva Pharmaceutical Industries
- Therapeuticsmd
- Tsumura & Co.
- Warner Chilcott Corp. (Subsidiary Of Actavis)
- Ziopharm Oncology
- Zosano Pharma Inc.
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll